CANCER & METABOLISM : Impact Factor & More
eISSN: 2049-3002pISSN: 2049-3002
Open AccessShare this on:
Key Metrics
Eigenfactor 
0.001 - 0.005
Impact Factor
5 - 10
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on CANCER & METABOLISM
CANCER & METABOLISM Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2390 | USD 2790 | GBP 2090 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in CANCER & METABOLISM ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CANCER & METABOLISM
Gut microbiota-derived indole-3-propionic acid promotes lymph node metastasis in gastric cancer via the aryl-hydrocarbon receptor signaling pathway
- 20 May 2026
- Cancer & Metabolism
Normoxic HIF\u03b1-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity
- 12 May 2026
- Cancer & Metabolism
BCAT1 inhibits glutamine-dependent Akt/mTOR signaling and nucleotide synthesis by initiating BTRC-mediated degradation of SLC3A2 in pancreatic adenocarcinoma.
- 7 May 2026
- Cancer & metabolism
Oncometabolite fumarate impairs ATR-CHK1 signaling by succinating RPA1 in fumarate hydratase-deficient renal cell carcinoma cells.
- 28 Apr 2026
- Cancer & metabolism
SENP1 drives de novo cholesterogenesis via disrupting SUMOylation-mediated SREBP2-FBXW7 interaction.
- 21 Apr 2026
- Cancer & metabolism
In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T.
- 18 Apr 2026
- Cancer & metabolism
Gut microbiota-derived indole-3-propionic acid promotes lymph node metastasis in gastric cancer via the aryl-hydrocarbon receptor signaling pathway
- 20 May 2026
- Cancer & Metabolism
Normoxic HIF\u03b1-mediated metabolic rewiring in cancer as a novel therapeutic target of tumor heterogeneity
- 12 May 2026
- Cancer & Metabolism
BCAT1 inhibits glutamine-dependent Akt/mTOR signaling and nucleotide synthesis by initiating BTRC-mediated degradation of SLC3A2 in pancreatic adenocarcinoma.
- 7 May 2026
- Cancer & metabolism
Oncometabolite fumarate impairs ATR-CHK1 signaling by succinating RPA1 in fumarate hydratase-deficient renal cell carcinoma cells.
- 28 Apr 2026
- Cancer & metabolism
SENP1 drives de novo cholesterogenesis via disrupting SUMOylation-mediated SREBP2-FBXW7 interaction.
- 21 Apr 2026
- Cancer & metabolism
In vivo characterization of the redox balance in IDH-wildtype glioblastomas: a J-difference edited MEGA-sLASER MRS study at 3T.
- 18 Apr 2026
- Cancer & metabolism
FAQs on CANCER & METABOLISM
How long has CANCER & METABOLISM been actively publishing? 
What is the publishing frequency of CANCER & METABOLISM?
How many articles did CANCER & METABOLISM publish last year?
What is the eISSN & pISSN for CANCER & METABOLISM?
Who is the publisher of CANCER & METABOLISM?
